Literature DB >> 29259850

The paradoxical role of tumor-infiltrating immune cells in lung cancer.

Xiaodan Zheng1, Yuhai Hu1, Chengfang Yao2.   

Abstract

Lung cancer remains one of the leading causes of death worldwide, and lung cancers have often already metastasized when diagnosed. Numerous studies have noted the infiltration of immune cells in the lung cancer microenvironment, but these cells play a dualistic role, i.e. they suppress and/or promote tumor development and growth based on tumor progression and different cytokines in the microenvironment. These tumor-infiltrating immune cells create different microenvironments depending on their type and interaction. Chemokines act as a bridge in this process by recruiting immune cells to the tumor site and they regulate the phenotypes and functions of those cells. The current review summarizes current knowledge about the tumor-infiltrating immune cells in lung cancer as well as the mechanisms involved in suppression and promotion of tumor development and growth.

Entities:  

Keywords:  Lung cancer; chemokine; infiltrating immune cells; tumor microenvironment

Year:  2017        PMID: 29259850      PMCID: PMC5735275          DOI: 10.5582/irdr.2017.01059

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  88 in total

Review 1.  Chemokines: multiple levels of leukocyte migration control.

Authors:  Bernhard Moser; Marlene Wolf; Alfred Walz; Pius Loetscher
Journal:  Trends Immunol       Date:  2004-02       Impact factor: 16.687

Review 2.  Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective.

Authors:  Casey T Weaver; Robin D Hatton
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

3.  Therapeutic potential of targeting IL-17.

Authors:  Sarah A Jones; Caroline E Sutton; Daniel Cua; Kingston H G Mills
Journal:  Nat Immunol       Date:  2012-11       Impact factor: 25.606

4.  The origin and function of tumor-associated macrophages.

Authors:  Yang Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2014-09-15       Impact factor: 11.530

5.  MicroRNA-21 negatively regulates Treg cells through a TGF-β1/Smad-independent pathway in patients with coronary heart disease.

Authors:  Sihui Li; Qian Fan; Shaolin He; Tingting Tang; Yuhua Liao; Jiangjiao Xie
Journal:  Cell Physiol Biochem       Date:  2015-09-18

6.  CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.

Authors:  Y Naito; K Saito; K Shiiba; A Ohuchi; K Saigenji; H Nagura; H Ohtani
Journal:  Cancer Res       Date:  1998-08-15       Impact factor: 12.701

7.  Variance of TNFAIP8 expression between tumor tissues and tumor-infiltrating CD4+ and CD8+ T cells in non-small cell lung cancer.

Authors:  Lingcheng Wang; Yinghua Song; Xuelin Men
Journal:  Tumour Biol       Date:  2013-10-19

8.  Local production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma.

Authors:  Jinyan Liu; Feng Li; Yu Ping; Liping Wang; Xinfeng Chen; Dan Wang; Ling Cao; Song Zhao; Bing Li; Pawel Kalinski; Stephen H Thorne; Bin Zhang; Yi Zhang
Journal:  Oncotarget       Date:  2015-09-22

9.  TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Authors:  Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

10.  Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancer.

Authors:  Laura E Edgington-Mitchell; Jai Rautela; Hendrika M Duivenvoorden; Krishnath M Jayatilleke; Wouter A van der Linden; Martijn Verdoes; Matthew Bogyo; Belinda S Parker
Journal:  Oncotarget       Date:  2015-09-29
View more
  13 in total

1.  Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study.

Authors:  Valentina Masciale; Giulia Grisendi; Federico Banchelli; Roberto D'Amico; Antonino Maiorana; Pamela Sighinolfi; Massimo Pinelli; Eleonora Lovati; Alessandro Stefani; Uliano Morandi; Massimo Dominici; Beatrice Aramini
Journal:  Ann Transl Med       Date:  2019-11

2.  Methylation Regulation of TLR3 on Immune Parameters in Lung Adenocarcinoma.

Authors:  Ang Li; Hongjiao Wu; Qinqin Tian; Yi Zhang; Zhi Zhang; Xuemei Zhang
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

3.  Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.

Authors:  Shuguang Zuo; Min Wei; Shiqun Wang; Jie Dong; Jiwu Wei
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

4.  Molecular Signature of Subtypes of Non-Small-Cell Lung Cancer by Large-Scale Transcriptional Profiling: Identification of Key Modules and Genes by Weighted Gene Co-Expression Network Analysis (WGCNA).

Authors:  Magdalena Niemira; Francois Collin; Anna Szalkowska; Agnieszka Bielska; Karolina Chwialkowska; Joanna Reszec; Jacek Niklinski; Miroslaw Kwasniewski; Adam Kretowski
Journal:  Cancers (Basel)       Date:  2019-12-21       Impact factor: 6.639

5.  Investigation on Potential Correlation Between Small Nuclear Ribonucleoprotein Polypeptide A and Lung Cancer.

Authors:  Maoxi Yuan; Chunmei Yu; Xin Chen; Yubing Wu
Journal:  Front Genet       Date:  2021-01-21       Impact factor: 4.599

6.  NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma.

Authors:  Cui Zhao; Jian Liu; Yifei Liu; Jianguo Zhang; Haomiao Zhou; Xin Qian; Hui Sun; Xuewen Chen; Miaosen Zheng; Tingting Bian; Lei Liu
Journal:  Cancer Cell Int       Date:  2021-04-20       Impact factor: 5.722

Review 7.  Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer.

Authors:  Mohamed Haider; Amr Elsherbeny; Valeria Pittalà; Valeria Consoli; Maha Ali Alghamdi; Zahid Hussain; Ghalia Khoder; Khaled Greish
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

8.  FGL2 is positively correlated with enhanced antitumor responses mediated by T cells in lung adenocarcinoma.

Authors:  Kai Yuan; Yanyan Feng; Hesong Wang; Lu Zhao; Wei Wang; Ting Wang; Yuyin Feng; Guangrui Huang; Anlong Xu
Journal:  PeerJ       Date:  2020-03-13       Impact factor: 2.984

9.  Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer.

Authors:  Jie Sun; Zicheng Zhang; Siqi Bao; Congcong Yan; Ping Hou; Nan Wu; Jianzhong Su; Liangde Xu; Meng Zhou
Journal:  J Immunother Cancer       Date:  2020-02       Impact factor: 13.751

10.  Multi-omics Data Analyses Construct TME and Identify the Immune-Related Prognosis Signatures in Human LUAD.

Authors:  Yuwei Zhang; Minglei Yang; Derry Minyao Ng; Maria Haleem; Tianfei Yi; Shiyun Hu; Huangkai Zhu; Guofang Zhao; Qi Liao
Journal:  Mol Ther Nucleic Acids       Date:  2020-07-23       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.